Walking measurably eased postpartum depression

Postpartum depression affects many new mothers, and demand for traditional treatment such as psychiatry has risen, a squeeze the COVID-19 pandemic made worse. Mothers also face practical barriers to care that most patients do not: childcare, time, cost and travel. Walking is free, familiar and fits around a baby, which makes it an unusually accessible candidate treatment if it actually works. Before this review, walking specifically had never been systematically summarised as a treatment for postpartum depression, so the question was overdue.

The authors searched seven electronic databases for randomised controlled trials published between 2000 and July 2021 in which walking was the sole or primary aerobic exercise. Five trials met the criteria, together involving 242 participants with a mean age of around 28.9 years, all with mild-to-moderate depression. Interventions ran for 12 weeks in four studies and 24 weeks in one. Every trial measured symptoms with the Edinburgh Postnatal Depression Scale, so all five could be pooled in a meta-analysis, alongside a simple narrative count of positive and null studies.

Relative to controls, walking produced a pooled reduction of 4.01 points on the Edinburgh scale from baseline to the end of the intervention, a drop the authors describe as clinically significant. The uncertainty around that figure was wide, and the included studies disagreed with each other substantially, so the true effect could be smaller or larger. The narrative summary added texture: interventions that were walking-only, supervised and group-based, and that included 90-120+ minutes per week of moderate-intensity walking, appeared to produce greater reductions in symptoms.

This is the first time walking has been summarised in a systematic way as a treatment for postpartum depression, extending a broader literature on exercise and mood into a modality with uniquely low barriers for mothers. The evidence base remains thin: five trials and 242 participants is a small foundation, and because everyone had mild-to-moderate symptoms, nothing here speaks to severe depression. Open questions include the ideal weekly dose, whether the group and supervision elements drive part of the benefit, and how walking compares directly with established treatments.

For a new mother struggling with low mood, this is a reason to see regular walking as more than fresh air: in these trials it shifted depression scores by an amount considered clinically meaningful. The patterns hint that structure helps, since supervised, group-based walking showed the strongest signals, which may say something about company as well as movement. This is informational rather than a substitute for professional care, and anyone with significant symptoms has every reason to seek support alongside whatever activity they choose.